AETHLON MEDICAL INC
For the period ended Mar 31, 2024. Filed Jun 27, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Jun 27, 2024
AEMD$5.47+3.0%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Equity
FOR THE YEARS ENDED MARCH 31, 2024 AND 2023
| ATTRIBUTABLE TO AETHLON MEDICAL, INC. | |||||||
|---|---|---|---|---|---|---|---|
| COMMON STOCK · ADDITIONAL PAID IN · ACCUMULATED · ACCUMULATED COMPREHENSIVE · NON- CONTROLLING · TOTAL | |||||||
| SHARES | AMOUNT | CAPITAL | DEFICIT | LOSS | INTERESTS | EQUITY | |
| BALANCE - MARCH 31, 2022 | 1,541,926 | $1,542 | $147,460,747 | $(130,329,181) | $– | $(141,708) | $16,991,400 |
| Issuances of common stock for cash under at the market program | 748,084 | 748 | 8,926,463 | – | – | – | 8,927,211 |
| Issuance of common shares upon vesting of restricted stock units and net stock option exercise | 9,249 | 9 | (12,502) | – | – | – | (12,493) |
| Loss on dissolution of subsidiary | – | – | – | – | – | 142,121 | 142,121 |
| Stock-based compensation expense | – | – | 1,051,898 | – | – | – | 1,051,898 |
| Net loss | – | – | – | (12,029,373) | – | (413) | (12,029,786) |
| Other comprehensive loss | – | – | – | – | (6,141) | – | (6,141) |
| BALANCE - MARCH 31, 2023 | 2,299,259 | $2,299 | $157,426,606 | $(142,358,554) | $(6,141) | $– | $15,064,210 |
| Issuances of common stock for cash under at the market program | 296,056 | 296 | 1,322,087 | – | – | – | 1,322,383 |
| Rounding for reverse split | 32 | – | – | – | – | – | – |
| Issuance of common shares upon vesting of restricted stock units | 34,378 | 34 | (34,812) | – | – | – | (34,778) |
| Reversal of accrued commission liability (see Note 6) | – | – | 404,120 | – | – | – | 404,120 |
| Stock-based compensation expense | – | – | 1,219,370 | – | – | – | 1,219,370 |
| Net loss | – | – | – | (12,208,174) | – | – | (12,208,174) |
| Other comprehensive loss | – | – | – | – | (799) | – | (799) |
| BALANCE - MARCH 31, 2024 | 2,629,725 | $2,629 | $160,337,371 | $(154,566,728) | $(6,940) | $– | $5,766,332 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.